Navigation Links
Medicure's MEND-CABG Trial Results Published in Peer Reviewed,Journal

tion therefore would have a significant positive impact on patients undergoing CABG surgery. Given the limited success of prophylactic drug therapy for atrial fibrillation, the beneficial effects of MC-1 are promising and warrant further evaluation in future studies."

About MEND-CABG

The MEND-CABG trial, completed in 2006, was a Phase 2 study involving 901 patients that evaluated MC-1 versus placebo in individuals undergoing CABG surgery at 42 investigational sites throughout Canada and the United States.

The 250 mg dose of MC-1 had a 37.2% reduction in the composite of cardiovascular death, non-fatal myocardial infarction (peak CK-MB ?100ng/ml), and non-fatal stroke versus placebo (p@028).

The reduction in the composite endpoint was driven by a significant 46.9% decrease in the incidence of non-fatal myocardial infarction (peak CK-MB ?100ng/ml) with the 250 mg dose of MC-1 versus placebo (p@008).

The clinical results reported at POD 30 were maintained throughout the 90 day follow-up period (POD 90). Safety analysis included in the MEND-CABG study demonstrated that MC-1 was well tolerated. No safety concerns were identified; the incidence of adverse events in the study was comparable across both treatment and control groups.

The MEND-CABG trial was the catalyst to Medicure's ongoing Phase 3 MEND-CABG II study.

About MEND-CABG II

The Phase 3 MEND-CABG II is a double-blind, randomized, placebo-controlled clinical trial that will enroll up to 3,000 patients undergoing CABG surgery at approximately 120 cardiac surgical centers throughout North America and Europe. Study patients will be randomized to receive placebo or MC-1 250 mg prior to surgery and for 30 days post operatively (POD 30). The primary efficacy endpoint of MEND-CABG II is the reduction in the composite of cardiovascular death and non-fatal myocardial infarction up to POD 30. Study patients will be followed for 60 days after treatment (90 days post op
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
3. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
4. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
5. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
6. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
7. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
8. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
9. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
10. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
11. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Medicure MEND CABG Trial Results Published Peer Reviewed Journal
(Date:7/10/2014)... 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... completed the sale to Galderma of all rights to ... by Valeant for $1.4 billion in cash, pursuant to ... completed its acquisition of Galderma. "We ... to a company that is firmly committed to the ...
(Date:7/10/2014)... , July 10, 2014 Decision Resources Group ... of the U.S. Food and Drug Administration,s (FDA) approval ... binder Velphoro, which was approved by the FDA in ... kidney disease (CKD) patients on dialysis. Other ... Nephrology (US) Q2 2014 : ...
(Date:1/15/2014)... As health officials across the Midwest warn against the widespread ... Michigan will offer free diagnostic testing for ... to administer tests and, in some cases, fill the matching ... the study. The Grand Rapids, Mich. ...
Breaking Medicine Technology:Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3
... Ala., Nov. 9 Surgical Care Affiliates ("SCA") today ... at 11:00 a.m. Eastern Time on Monday, November 16, ... A 30-day replay will be available approximately an ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080812/CLTU111LOGO ) ...
... Mass., Nov. 9 Boston Scientific Corporation (NYSE: ... the 38th annual Global Congress for Minimally Invasive Gynecology ... Results from two clinical studies will be presented ... systems and mid-urethral sling systems used to treat pelvic ...
Cached Medicine Technology:Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 2Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 3Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 4Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 5
(Date:7/11/2014)... Woodland Hills permanent teeth in one day ... Art Institute in Woodland Hills and Oxnard, Calif., will speak ... Del Rey, Calif. , The award-winning prosthodontist, international speaker ... teeth in one day dental procedure at 1:30 p.m. Friday, ... developed 15 years ago, Dr. Jivraj said. Getting new teeth ...
(Date:7/11/2014)... LENEXA, Kan. (PRWEB) July 11, 2014 B. ... to healthcare providers, has been retained to lead a national ... Health System in Bend, Ore. The top executive ... has recently placed more than 900 healthcare executives into organizations. ... medical providers, St. Charles Health System is the largest provider ...
(Date:7/11/2014)... July 11, 2014 This is ... state of the Cholesterol industry in Global and ... the industry, including definitions, applications and industry chain ... analysis are provided with a focus on history, ... A comparison between the international and Chinese situation ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Growing old was thought ... then. However, in recent studies, it was shown that many of ... credence behind them. As it turns out, the elderly can still ... , Of course, with all the time in the world, older ... them to indulge their passions in the twilight of their lives. ...
(Date:7/11/2014)... July 11, 2014 Hands-On ... this August in New York. This ... , -Myofascial Trigger Point Therapy, -Strain ... & Thrust Manipulation, -Neuroobilization & Neurodynamics, -Proprioceptive ... to a single, isolated manual therapy school ...
Breaking Medicine News(10 mins):Health News:Woodland Hills Dental Expert Speaking at Nobel Biocare World Symposium in One Week 2Health News:Woodland Hills Dental Expert Speaking at Nobel Biocare World Symposium in One Week 3Health News:Woodland Hills Dental Expert Speaking at Nobel Biocare World Symposium in One Week 4Health News:Woodland Hills Dental Expert Speaking at Nobel Biocare World Symposium in One Week 5Health News:St. Charles Health System Retains B. E. Smith to Recruit New CNO 2Health News:St. Charles Health System Retains B. E. Smith to Recruit New CNO 3Health News:Cholesterol Industry 2014 Development Trends in Global & China Regions in a New Research Study Available at DeepResearchReports.com 2Health News:Cholesterol Industry 2014 Development Trends in Global & China Regions in a New Research Study Available at DeepResearchReports.com 3Health News:It’s All Free For Seniors Review, How To Take Advantage of What Life Has to Offer In Old Age – Vinamy.com 2Health News:It’s All Free For Seniors Review, How To Take Advantage of What Life Has to Offer In Old Age – Vinamy.com 3Health News:Hands-On Seminars, the Leader in Manual Therapy Continuing Education, Announces Series of Comprehensive Hands-On Training Courses 2
... Oct. 1 Marking a new chapter in the realization ... disabilities, the Training, Education & Research Institute (TERI, Inc.) today ... Center for Research & Life Planning. Set on 20 ... will directly address the crisis of a growing and aging ...
... Renowned orthopaedic and sports medicine surgeon Dr. James Andrews ... taking care of elite professional athletes. However, both organizations ... and new research is now focused on them . ... Sports Medicine in Gulf Breeze, Fla ., founded by ...
... Reportlinker.com announces that a new market research report ... Pharmaceutical Packaging , http://www.reportlinker.com/p0127773/World-Pharmaceutical-Packaging.html , ... Global demand for pharmaceutical packaging will rise 5.3 ... The developed countries of Western Europe, the US and ...
... Scientists from the U.S. Department of Energy,s Lawrence ... uncovered the role played by the least-understood part of ... repair breaks in DNA strands, a process that helps ... the puzzle in place, scientists can better understand how ...
... can have children is one of the major concerns ... fertility can be compromised by cancer treatment. For cancer ... by researchers at Fred Hutchinson Cancer Research Center may ... impact their newborns. The studies, presented as companion papers ...
... the University of Louisville will be the only ... that last week announced they had enabled paralyzed ... Dr. Susan Harkema, the University of Louisville,s ... director at the university,s Kentucky Spinal Cord Injury ...
Cached Medicine News:Health News:Construction Begins on $50 Million Campus for Autism and Developmental Disability Life Quality 2Health News:Construction Begins on $50 Million Campus for Autism and Developmental Disability Life Quality 3Health News:Preventing Injuries in Firefighters Nationwide is New Research Focus for Top Sports Doc James Andrews, M.D. and Athletes' Performance 2Health News:Preventing Injuries in Firefighters Nationwide is New Research Focus for Top Sports Doc James Andrews, M.D. and Athletes' Performance 3Health News:Preventing Injuries in Firefighters Nationwide is New Research Focus for Top Sports Doc James Andrews, M.D. and Athletes' Performance 4Health News:Preventing Injuries in Firefighters Nationwide is New Research Focus for Top Sports Doc James Andrews, M.D. and Athletes' Performance 5Health News:Reportlinker Adds World Pharmaceutical Packaging Report 2Health News:Reportlinker Adds World Pharmaceutical Packaging Report 3Health News:Reportlinker Adds World Pharmaceutical Packaging Report 4Health News:Reportlinker Adds World Pharmaceutical Packaging Report 5Health News:Reportlinker Adds World Pharmaceutical Packaging Report 6Health News:Reportlinker Adds World Pharmaceutical Packaging Report 7Health News:Reportlinker Adds World Pharmaceutical Packaging Report 8Health News:Reportlinker Adds World Pharmaceutical Packaging Report 9Health News:Reportlinker Adds World Pharmaceutical Packaging Report 10Health News:Scientists decipher missing piece of first-responder DNA repair machine 2Health News:Scientists decipher missing piece of first-responder DNA repair machine 3Health News:Studies find few risks to newborn offspring of parents who are childhood cancer survivors 2
BD Beaver Cataract blade, 30.0 mm long x 2.2 mm wide, designed for ICCE and ECCE procedures, designed for ICCE and ECCE, sterile....
BD Beaver Chondroplastic blade, sharp on two sides, curved, sterile...
BD Beaver Meniscus blade, 7 mm flat (4/bx, 1 bx/ca), specially designed maximum leverage and visibility, cutting edge: 7 mm, sterile....
... accurate testing of large oculomotor ... Fits all standard trial frames. ... of thin optical quality acrylic ... includes a display box. Available ...
Medicine Products: